Skip to main content

Find Clinical Trials

Home
Conditions
Retroviridae Infections

Clinical trial condition

Retroviridae Infections

Explore clinical trials studying Retroviridae Infections. Study availability and eligibility vary by location and protocol.

5,659 public trials 307 recruiting studies

Refine in advanced search Browse all conditions

Retroviridae Infections trial results

Recruiting

ALS Research Collaborative

NCT06885918

Conditions: AIDS-Related Complex, ALS (Amyotrophic Lateral Sclerosis), ALS With Frontotemporal Dementia (ALS/FTD), +27 more
Locations: ALS Therapy Development Institute Watertown, Massachusetts, United States

View Trial Details

Recruiting

A Long-term Follow-up of the HIV-NAT Cohort

NCT00411983

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: HIV-NAT, Thai Red Cross AIDS Research Center Bangkok, Thailand

View Trial Details

Recruiting

A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection

NCT05328765

Conditions: Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +25 more
Locations: A.C. Camargo Cancer Center São Paulo, Brazil

View Trial Details

Recruiting

Tools to Identify People At Risk or Already Infected with HIV and HCV

NCT06528626

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Maria J. Vivancos-Gallego Madrid, Spain

View Trial Details

Recruiting

Observational Pharmaco-Epidemiology Research & Analysis

NCT03813862

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cardiovascular Diseases, +31 more
Locations: Epividian Durham, North Carolina, United States

View Trial Details

Recruiting

Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein

NCT06441123

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: CHU de MONTPELLIER Montpellier, France

View Trial Details

Recruiting

Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

NCT06424964

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Saint-Pierre University Hospital Brussels, Belgium

View Trial Details

Recruiting

PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.

NCT06807736

Conditions: Behavior, Blood-Borne Infections, Coitus, +16 more
Locations: Desmond Tutu Health Foundation Cape Town, Western Province, South Africa

View Trial Details

Recruiting

HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART)

NCT06100211

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Manchester University NHS Foundation Trust Manchester, Greater Manchester, United Kingdom

View Trial Details

Recruiting

Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection

NCT03449706

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations: UZ Gent Ghent, Oost-Vlaanderen, Belgium

View Trial Details